免费精品AB,亚洲日韩性欧美中文字幕,鲁丝无码一区二区三区,精品久久久久久成人AV,看av免费毛片手机播放,精品国际久久久久999波多野,又黄又爽又刺激又色的视频,亚洲无线码一区二区三区在线观看

        Scientists develop new form of antibiotic to combat multidrug resistant bacteria

        Source: Xinhua| 2018-09-28 12:22:28|Editor: Li Xia
        Video PlayerClose

        SYDNEY, Sept. 28 (Xinhua) -- A new antibiotic, developed by an Australian led-team of scientists, revealed on Friday, could present a solution to the problem of drug resistant bacteria, which is expected to present an ever increasing concern in the coming century.

        The new kind of antibiotic was developed to limit multidrug resistance by targeting and disrupting key elements in bacterial cells, by scientists from Griffith University (GU), in collaboration with colleagues from Queensland University of Technology, the United States' Indiana University and China's Dezhou University.

        "We tried to develop a new type of antibiotics that act differently than what we are using right now," Professor Yaoqi Zhou from GU's Institute for Glycomics told Xinhua.

        "The way most antibiotics stop key functions in bacteria is that they bind to the surface of an essential protein so that it is unable to perform its normal function."

        "Our technique with this new antibiotic approach is different -- instead of binding to the surface of the protein, we disrupt the structure of the protein, which stops it functioning."

        In one test Zhou said, the team saw a 500-fold resistance develop to a commonly used antibiotic over 30 days, where as their newly developed antibiotic encountered no developed resistance at all.

        Additionally the new drug may be useful in cancer treatment, another area where drug resistance is a major hurdle.

        "What we've found in the concept is that it's not only working for antibiotics but should also work for anti-cancer, which also has a lot of problems in terms of drug resistance, also anti-viral - viral infections have a lot of problems with anti-drug resistance," Zhou said.

        "So I think this is a concept that should be useful for any other kinds of disease which also has problems with drug resistance issues."

        Although still in the early theoretical stage, Zhou is hopeful that the method will progress to animal testing and eventually clinical trials, and provide an answer to what is an increasingly urgent international crisis.

        TOP STORIES
        EDITOR’S CHOICE
        MOST VIEWED
        EXPLORE XINHUANET
        010020070750000000000000011100001374987631